Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times of Nebraska.
Press releases published on August 21, 2025
サイ・ライフ・サイエンシズ (Sai Life Sciences)、短期的な気候目標に対するSBTiの認定を取得
GlobeNewswire
·
August 21, 2025
インド・ハイデラバード発, Aug. 21, 2025 (GLOBE NEWSWIRE) -- イノベーターに焦点を当てた受託研究、開発…
Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at …
GlobeNewswire
·
August 21, 2025
PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for …
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
GlobeNewswire
·
August 21, 2025
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical, non-clinical …
Food Colors Market Growth: Bright Future Ahead with USD 6.0 Billion by 2028 | Europe Holds Market Leadership
GlobeNewswire
·
August 21, 2025
Delray Beach, FL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global food colors market is undergoing a vibrant transformation, fueled by rising demand for processed foods, evolving consumer preferences, and stricter food regulations. According to a recent …
Neue Technologie zur Gesichtserkennung von Imprivata für schnelle, passwortlose Authentifizierung
GlobeNewswire
·
August 21, 2025
LANGENFELD, Deutschland, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Imprivata, ein führender Anbieter von Zugriffsmanagementlösungen für das Gesundheitswesen und andere geschäftskritische Branchen, hat eine fortschrittliche Gesichtserkennungstechnologie vorgestellt …
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
GlobeNewswire
·
August 21, 2025
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President …
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
GlobeNewswire
·
August 21, 2025
Achieving the primary endpoint in both Denali and the first NCX 470 Phase 3 trial, Mont Blanc, meets efficacy requirements for approval in the U.S. and China NCX 470 was also superior to latanoprost in the reduction of intraocular pressure (IOP) from …
Nicox annonce des résultats positifs pour NCX 470 dans l’étude de Phase 3 Denali chez des patients atteints de glaucome
GlobeNewswire
·
August 21, 2025
21 août 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que l’administration quotidienne en une seule …
Herantis Pharma releases 1H 2025 report today
GlobeNewswire
·
August 21, 2025
Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available at the Company’s …
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
August 21, 2025
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at an offering price of $0.52 per share and, to certain …
Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use
GlobeNewswire
·
August 21, 2025
SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 …
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
GlobeNewswire
·
August 21, 2025
MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated …